Stocks · Korea 344860 KOSDAQ

Innogene

1,298원 +0.23% Market cap 195억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER49.92x
PBR1.01x
EPS26 KRW
BPS1,288 KRW
ROE1.12%
DPS90 KRW

Returns and 52-week range

1W-7.22%
1M-3.21%
3M-3.28%
6M-16.42%
1Y-26.67%
YTD-32.01%
52W high2,800원
52W low1,099원
From 52W high-53.64%

Financial results (separate)

PeriodRevenueOperating incomeNet incomeOP margin
202291억15억13억16.3%
2023101억12억14억12.1%
202489억6억9억7.0%
202582억4,492,321원3억0.1%
Quarterly
2024 4Q21억33,281,423원2억1.6%
2025 1Q18억-26,982,648원45,371,656원-1.5%
2025 2Q19억-48,187,899원-27,538,489원-2.5%
2025 3Q21억-29,829,398원59,370,684원-1.4%
2025 4Q24억1억2억4.5%
2026 1Q26억-2억-96,112,606원-6.8%

Company

CEO이광훈, 정기철
Founded2005-09-07
Fiscal year end12
Address: 서울특별시 구로구 디지털로33길 28, 301호

Peers in the same sector

CompanyMarket capP/EP/B1M
에스폴리텍197억—0.33+2.89%
엔피케이193억17.180.42+0.00%
세화피앤씨203억17.500.50+9.62%
아우딘퓨쳐스193억—0.86-8.64%
세림B&G212억11.320.59-4.23%
전진바이오팜186억—1.07+5.93%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.